HomeBMY • SWX
add
Bristol-Myers Squibb Co
Nakaraang pagsara
CHFÂ 42.54
Sakop ng taon
CHFÂ 42.54 - CHFÂ 44.50
Market cap
127.01B USD
Average na Volume
17.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 12.50B | 1.30% |
Gastos sa pagpapatakbo | 5.47B | -13.56% |
Net na kita | 1.09B | 1,409.72% |
Net profit margin | 8.69 | 1,398.28% |
Kita sa bawat share | 1.26 | -24.55% |
EBITDA | 4.54B | -2.17% |
Aktuwal na % ng binabayarang buwis | 26.12% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 10.67B | -1.71% |
Kabuuang asset | 90.04B | -2.77% |
Kabuuang sagutin | 71.53B | -6.14% |
Kabuuang equity | 18.51B | — |
Natitirang share | 2.04B | — |
Presyo para makapag-book | 4.69 | — |
Return on assets | 9.42% | — |
Return on capital | 13.01% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.09B | 1,409.72% |
Cash mula sa mga operasyon | 1.97B | -55.53% |
Cash mula sa pag-invest | -1.46B | -643.88% |
Cash mula sa financing | -6.03B | -267.17% |
Net change in cash | -5.51B | -324.45% |
Malayang cash flow | 669.62M | -84.21% |
Tungkol
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Itinatag
1887
Headquarters
Website
Mga Empleyado
32,500
